Compositions and methods for treating hypertension
US9605047B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2013 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | May 8, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The technology described herein is directed to agents that reduce the level of oxidant-modified ET-B Cys405, Cys403, or Cys402 and the identification and use of such agents for, e.g. to treat hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.